{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:27:59Z","timestamp":1788064079280,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.det.2015.08.006","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T18:19:41Z","timestamp":1448561981000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Medical Treatments of Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"34","author":[{"given":"Hessel H.","family":"van der Zee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne P.","family":"Gulliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2015.08.006_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2015.08.006_bib2","unstructured":"Gulliver WP, Zouboulis CC, Errol Prens EP. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European Guidelines for Hidradenitis Suppurativa. Reviews of Endocrine and Metabolic Disorders, in press."},{"issue":"7","key":"10.1016\/j.det.2015.08.006_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1468-3083.2011.04123.x","article-title":"Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa","volume":"26","author":"Gulliver","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2015.08.006_bib4","unstructured":"Blok JL, Jonkman MF, Horvath B. Results of the first prospective open label study investigating the effectiveness and safety of usekinumab in hidradenitis suppurativa. EADV Congress. Amsterdam, The Netherlands, October 8\u201312, 2014."},{"key":"10.1016\/j.det.2015.08.006_bib5","series-title":"Hidradenitis suppurativa","first-page":"138","author":"Jemec","year":"2006"},{"key":"10.1016\/j.det.2015.08.006_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2230.1995.tb01351.x","article-title":"Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases","volume":"20","author":"Firooz","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/jid.1958.124","article-title":"Preliminary studies of the effect of hydrocortisone on hidradenitis suppurativa","volume":"31","author":"Danto","year":"1958","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2015.08.006_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001050170015","article-title":"Acne inversa: a dapsone-sensitive dermatosis","volume":"52","author":"Hofer","year":"2001","journal-title":"Hautarzt"},{"key":"10.1016\/j.det.2015.08.006_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2230.2005.01983.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin","volume":"31","author":"Rose","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib12","first-page":"289P","article-title":"Cyclosporin-responsive hidradenitis suppurativa","volume":"88","author":"Buckley","year":"1995","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.det.2015.08.006_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","article-title":"Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy","volume":"115","author":"Sawers","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.298.6665.28","article-title":"Hidradenitis suppurativa associated with use of oral contraceptives","volume":"298","author":"Stellon","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.det.2015.08.006_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"40","author":"Boer","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2015.08.006_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2230.1999.00451.x","article-title":"Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin","volume":"24","author":"Fearfield","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9378(88)90766-1","article-title":"Hidradenitis suppurativa of the anogenital region: response to isotretinoin","volume":"158","author":"Brown","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.det.2015.08.006_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(84)70199-X","article-title":"Evaluation of isotretinoin treatment of hidradenitis suppurativa","volume":"11","author":"Dicken","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib20","first-page":"252","article-title":"Hidradenitis suppurativa-lack of success with 13-cis-retinoic acid","volume":"107","author":"Jones","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2230.1986.tb00512.x","article-title":"Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin","volume":"11","author":"Norris","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(88)80251-2","article-title":"Successful treatment of hidradenitis suppurativa with acitretin","volume":"19","author":"Hogan","year":"1988","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib25","first-page":"287","article-title":"Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report","volume":"69","author":"Scheman","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.det.2015.08.006_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1992.tb00693.x","article-title":"Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate","volume":"126","author":"Chow","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2230.2009.03377.x","article-title":"Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa","volume":"35","author":"Boer","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2133.2007.08069.x","article-title":"Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: a retrospective review of 63 cases","volume":"157","author":"Goo","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"van der Zee","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2015.08.006_bib30","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2230.2008.03121.x","article-title":"Long-standing hidradenitis suppurativa treated effectively with metformin","volume":"34","author":"Arun","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2015.08.006_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study","volume":"214","author":"Brocard","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2015.08.006_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity","volume":"148","author":"Dreno","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/01.prs.0000184354.32111.dc","article-title":"Treatment of hidradenitis suppurativa with botulinum toxin A","volume":"116","author":"O'Reilly","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.det.2015.08.006_bib35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1524-4725.2009.01231.x","article-title":"Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A","volume":"35","author":"Feito-Rodriguez","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2015.08.006_bib36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/ced.12380","article-title":"Hidradenitis suppurativa treated with Clostridium botulinum toxin A","volume":"39","author":"Khoo","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib37","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.jaad.2014.06.031","article-title":"Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus","volume":"71","author":"Ducroux","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.tp.0000235170.21344.07","article-title":"Inactivity of hidradenitis suppurativa after renal transplantation","volume":"82","author":"Arnadottir","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.det.2015.08.006_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.13346","article-title":"Fumarates, a new treatment option for therapy-resistant hidradenitis suppurativa: a prospective open-label pilot study","volume":"172","author":"Deckers","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.006_bib40","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:54:37Z","timestamp":1537170877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863515001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0733863515001023"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2015.08.006","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Treatments of Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2015.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}